|
Topical dapsone gel engenders screening requirement.(Dermatologic Therapy)
Publication: Skin & Allergy News Publication Date: 01-DEC-05 Author: McNamara, Damian
|
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2005 International Medical News Group
Topical dapsone gel, a new option for the treatment of acne vulgaris, requires screening patients for an enzyme deficiency.
Dermatologists are required to test patients for a lack of the glucose 6-phosphate dehydrogenase (G6PD) enzyme before prescribing Aczone (dapsone) gel, 5% (QLT Inc.). Enzyme-deficient patients should be closely monitored...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Skin & Allergy News |
Could it be restless legs syndrome?(Clinical Rounds)
December 01, 2005
|
In preterm infants, opportunistic fungi can lead to systemic infection...
December 01, 2005
|
Cutaneous B-cell lymphoma tied to infection in Europe.(Clinical Rounds...
December 01, 2005
|
Consumer antibacterial soaps may not deliver; antiseptic home-use soap...
December 01, 2005
|
Follow up melanoma survivors with exams.(Clinical Rounds)
December 01, 2005
|
|
| Find companies classified under Measuring controlling devices not elsewhere classified |
| Find companies classified under Pharmaceutical preparations |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
